Anti-abortion groups are pressing the Trump Justice Department and Food and Drug Administration to quickly reverse Biden administration policies on abortion pills and impose a clampdown, including the use of a 19th-century anti-obscenity law to block the mailing of the drugs.

Judge Matthew Kacsmaryk, a Trump appointee, allowed three states to go forward with a lawsuit that seeks to change how mifepristone is used.

The anti-abortion movement has launched a pressure campaign urging President Donald Trump’s administration to take steps toward a nationwide ban on medication abortion, the method used in nearly two-thirds of all abortions nationwide.

If further research confirms its findings, Americans seeking abortions may soon have a safe and effective workaround in places where mifepristone is restricted—and American abortion opponents ...

The new Trump administration could put a stop to pending litigation on the abortion pill mifepristone and other federal abortion policies through changes at the Department of Health and Human Services, according to a top anti-abortion lawyer involved in several pending cases.

Committee chairwoman cites high volume of speakers for decision to prevent lawmakers from engaging with non-agency experts, doctors.

Mifepristone is under attack by abortion opponents, with several states seeking in federal court to restrict its use.

Abortion pills are a combination of two medications- mifepristone and misoprostol, which are consumed in two separate doses. Now, researchers have discovered an alternative to mifepristone.

At the March for Life rally, the president said he was ‘proud to be a participant’ in the Supreme Court’s reversal of Roe v. Wade in 2022

The proposal would enable doctors and other medical professionals who prescribe mifepristone, misoprostol and generic alternatives – drugs used to abort a pregnancy in early stages – to be identified by their medical practice instead of their name.

New research suggests that a pill used for emergency contraception may help women have an abortion. Here, MDs weigh in on how this will impact access.